Rice Hall James & Associates’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.9M Buy
148,386
+3,340
+2% +$749K 1.89% 9
2025
Q4
$30.9M Sell
145,046
-2,044
-1% -$422K 1.7% 12
2025
Q3
$29.2M Sell
147,090
-13,020
-8% -$2.43M 1.59% 14
2025
Q2
$27.6M Sell
160,110
-686
-0.4% -$112K 1.49% 20
2025
Q1
$25.1M Sell
160,796
-3,092
-2% -$442K 1.47% 20
2024
Q4
$22.6M Buy
163,888
+3,274
+2% +$430K 1.24% 22
2024
Q3
$24M Buy
160,614
+8,958
+6% +$1.21M 1.3% 22
2024
Q2
$20.7M Sell
151,656
-10,756
-7% -$1.46M 1.24% 19
2024
Q1
$24.6M Sell
162,412
-6,471
-4% -$924K 1.4% 18
2023
Q4
$21.3M Sell
168,883
-904
-0.5% -$90.1K 1.23% 20
2023
Q3
$15.9M Sell
169,787
-3,676
-2% -$344K 1.01% 27
2023
Q2
$15.5M Buy
173,463
+18,535
+12% +$1.61M 0.88% 34
2023
Q1
$16.6M Buy
154,928
+9,189
+6% +$1.05M 0.94% 29
2022
Q4
$17.8M Buy
145,739
+9,294
+7% +$1.08M 1.02% 27
2022
Q3
$14.1M Sell
136,445
-26,543
-16% -$2.52M 0.82% 37
2022
Q2
$15.2M Buy
162,988
+28,088
+21% +$2.65M 0.73% 41
2022
Q1
$15.8M Buy
134,900
+35,039
+35% +$4.06M 0.63% 49
2021
Q4
$13.4M Buy
99,861
+23,095
+30% +$3.44M 0.48% 52
2021
Q3
$12.2M Buy
76,766
+36,593
+91% +$5.01M 0.45% 63
2021
Q2
$5.29M Hold
40,173
0.19% 90
2021
Q1
$5.18M Sell
40,173
-1,810
-4% -$275K 0.17% 109
2020
Q4
$7M Buy
41,983
+19,696
+88% +$3.26M 0.25% 78
2020
Q3
$3.44M Buy
+22,287
New +$3.2M 0.14% 119

Other funds holding ASND